CAS: 558447-26-0
Ref: IN-DA00DB4P
| 25mg | 184.00 € | ||
| 50mg | 225.00 € | ||
| 100mg | 534.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 54-BUP04495
| 25mg | 592.00 € | ||
| 50mg | 863.00 € | ||
| 100mg | 1,225.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025
![(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine](https://static.cymitquimica.com/products/3D/thumb/IXA44726.jpg)
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
CAS:558447-26-0
Please enquire for more information about (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine including the price, delivery time and more detailed …
Formula:
C21H27N5
Purity:
Min. 95 Area-%
Color and Shape:
Powder
Molecular weight:
349.48 g/mol
Ref: 3D-IXA44726
| 5mg | 278.00 € | ||
| 10mg | 417.00 € | ||
| 25mg | 603.00 € | ||
| 50mg | 879.00 € | ||
| 100mg | 1,324.00 € |
Estimated delivery in United States, on Friday 9 May 2025
Mavorixafor
CAS:558447-26-0
Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of …
Formula:
C21H27N5
Purity:
98.56%
Color and Shape:
Solid
Molecular weight:
349.47
Ref: TM-TQ0174
| 1mg | 70.00 € | ||
| 2mg | 92.00 € | ||
| 5mg | 153.00 € | ||
| 10mg | 220.00 € | ||
| 25mg | 396.00 € | ||
| 50mg | 588.00 € | ||
| 100mg | 835.00 € | ||
| 1mL*10mM (DMSO) | 249.00 € |
Estimated delivery in United States, on Wednesday 4 Jun 2025
![(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine](https://static.cymitquimica.com/products/10/thumb/F229693.jpg)
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
CAS:558447-26-0
Purity:
97.0%
Molecular weight:
349.48199462890625
Ref: 10-F229693
| 250mg | Discontinued | Request information |
